Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharma
Inside the ICE House
•
21m
AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. Eli Lilly is leading the way, appointing Thomas Fuchs as its first Chief AI Officer to integrate AI across its pipeline. A NASA and Mount Sinai veteran, Fuchs is turning Lilly’s data into a competitive edge. He joins Inside the ICE House to share how Lilly is building the AI-powered medicine company of the future.
Up Next in Inside the ICE House
-
Radian's Rick Thornberry & Inigo's Ri...
Radian Group is expanding beyond mortgage insurance with its acquisition of Inigo, marking a pivotal step toward becoming a diversified global insurer. CEO Rick Thornberry and Inigo CEO Richard Watson go Inside the ICE House to discuss the strategy behind the deal and how it accelerates Radian’s ...
-
He's not the Oracle of Delphi, but he...
With the exception of Caesar's Palace, Las Vegas bears little resemblance to ancient Corinth, except that sometimes it beckons the great thinkers of the day. Against the backdrop of ICE Experience 2024, our gathering of the mortgage technology industry, former Treasury Secretary Larry Summers sat...
-
Nick Fink, CEO of Fortune Brands Inno...
Nick Fink, CEO of Fortune Brands Innovations (NYSE: FBIN), makes a return visit to the show to discuss the company’s “before” and “after” makeover since his first appearance on Inside the ICE House two years ago. Nick and Josh dove deep inside company’s focus on the digitization of its Water, Out...
